Evergreen State Press
SEE OTHER BRANDS

Your daily news update on Washington state

Evergreen State Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Evergreen State Press.

Press releases published on May 30, 2025

Armstrong Stove and Spa Announces Name Change, Reflecting Growth and Expanded Vision

Armstrong Stove and Spa Announces Name Change, Reflecting Growth and Expanded Vision

YAKIMA, WA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Armstrong Stove and Spa is excited to announce that it is officially changing its name to Serenity Hearth …

UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA’s Briefing Document and Subsequent ODAC Vote Against UGN-102 – Hagens Berman

UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA’s Briefing Document and Subsequent ODAC Vote Against UGN-102 – Hagens Berman

SAN FRANCISCO, May 30, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen …

Avista issues all-source request for proposals for new energy and capacity resources along with Demand Response

Avista issues all-source request for proposals for new energy and capacity resources along with Demand Response

SPOKANE, Wash., May 30, 2025 (GLOBE NEWSWIRE) -- Avista, through a request for proposal (RFP), is seeking proposals from bidders to add energy and capacity including distributed energy resources, to meet projected resource needs. In addition, Avista is …

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

SEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service